⌘K

Home/Filings/4/0001290929-11-000016

4//SEC Filing

Sterling Howard David 4

Accession 0001290929-11-000016

CIK 0001060426other

View on SEC.gov Company Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 3:29 PM ET

Size

4.7 KB

Accession

0001290929-11-000016

Insider Transaction Report

Form 4

Period: 2011-05-27

AOXING PHARMACEUTICAL COMPANY, INC.AXN

Sterling Howard David

Director

Transactions

Award
Common Stock
2011-05-27$1.84/sh+20,000$36,800→ 40,000 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AOXING PHARMACEUTICAL COMPANY, INC.

CIK 0001060426

Entity typeother

Related Parties

1

filerCIK 0001522225

Filing Metadata

Form type: 4
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 3:29 PM ET
Size: 4.7 KB

View on SEC.gov